 Laurel Beaty
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Outpatients | 7 | 2024 | 396 | 0.980 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2025 | 157 | 0.410 |
Why?
| | Oxygen | 2 | 2025 | 931 | 0.330 |
Why?
| | Antibodies, Monoclonal | 6 | 2024 | 1430 | 0.290 |
Why?
| | Breast Neoplasms | 3 | 2023 | 2253 | 0.240 |
Why?
| | Mullerian Ducts | 1 | 2025 | 12 | 0.240 |
Why?
| | Prader-Willi Syndrome | 1 | 2025 | 31 | 0.240 |
Why?
| | Uterine Hemorrhage | 1 | 2025 | 37 | 0.240 |
Why?
| | Hospitalization | 6 | 2024 | 2199 | 0.240 |
Why?
| | Hypogonadism | 1 | 2025 | 92 | 0.230 |
Why?
| | Urogenital Abnormalities | 1 | 2025 | 64 | 0.220 |
Why?
| | Hormone Replacement Therapy | 1 | 2025 | 100 | 0.220 |
Why?
| | Health Care Rationing | 1 | 2024 | 59 | 0.220 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 66 | 0.220 |
Why?
| | Levonorgestrel | 1 | 2024 | 38 | 0.210 |
Why?
| | Alanine | 1 | 2024 | 152 | 0.210 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2024 | 29 | 0.210 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 189 | 0.210 |
Why?
| | Antibodies, Viral | 2 | 2024 | 625 | 0.200 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 45 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2024 | 744 | 0.180 |
Why?
| | Obstetrics | 1 | 2023 | 163 | 0.180 |
Why?
| | Gynecology | 1 | 2023 | 168 | 0.170 |
Why?
| | Burns | 1 | 2025 | 325 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2022 | 119 | 0.170 |
Why?
| | Antibodies, Neutralizing | 4 | 2022 | 286 | 0.160 |
Why?
| | Machine Learning | 1 | 2024 | 493 | 0.150 |
Why?
| | Critical Illness | 1 | 2025 | 811 | 0.150 |
Why?
| | Body Mass Index | 2 | 2024 | 2389 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2022 | 264 | 0.140 |
Why?
| | Adult | 13 | 2025 | 37929 | 0.140 |
Why?
| | Wounds and Injuries | 1 | 2025 | 758 | 0.140 |
Why?
| | Sentinel Lymph Node Biopsy | 3 | 2023 | 115 | 0.140 |
Why?
| | Kidney | 1 | 2025 | 1468 | 0.140 |
Why?
| | Ovarian Neoplasms | 1 | 2023 | 565 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2024 | 940 | 0.130 |
Why?
| | Lymph Node Excision | 3 | 2023 | 171 | 0.130 |
Why?
| | Mass Screening | 1 | 2025 | 1287 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 938 | 0.120 |
Why?
| | Retrospective Studies | 8 | 2025 | 15657 | 0.120 |
Why?
| | Melanoma | 1 | 2022 | 760 | 0.120 |
Why?
| | Humans | 22 | 2025 | 137585 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2022 | 855 | 0.120 |
Why?
| | Mastectomy | 2 | 2023 | 137 | 0.100 |
Why?
| | Axilla | 2 | 2023 | 47 | 0.090 |
Why?
| | Female | 12 | 2025 | 73304 | 0.090 |
Why?
| | Lymphatic Metastasis | 2 | 2023 | 352 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2023 | 491 | 0.080 |
Why?
| | Treatment Outcome | 4 | 2025 | 10811 | 0.080 |
Why?
| | Young Adult | 4 | 2025 | 13209 | 0.070 |
Why?
| | Middle Aged | 5 | 2025 | 33479 | 0.060 |
Why?
| | Puberty, Delayed | 1 | 2025 | 9 | 0.060 |
Why?
| | Amenorrhea | 1 | 2025 | 31 | 0.060 |
Why?
| | Adolescent | 4 | 2025 | 21513 | 0.060 |
Why?
| | Burn Units | 1 | 2025 | 48 | 0.060 |
Why?
| | Congenital Abnormalities | 1 | 2025 | 92 | 0.060 |
Why?
| | Intrauterine Device Expulsion | 1 | 2024 | 9 | 0.050 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2024 | 208 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 5742 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4565 | 0.050 |
Why?
| | Salpingo-oophorectomy | 1 | 2023 | 18 | 0.050 |
Why?
| | Male | 6 | 2025 | 67762 | 0.050 |
Why?
| | Multilocus Sequence Typing | 1 | 2022 | 16 | 0.050 |
Why?
| | Contraceptive Agents, Female | 1 | 2024 | 80 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 564 | 0.050 |
Why?
| | Ovariectomy | 1 | 2023 | 152 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 74 | 0.050 |
Why?
| | Trauma Centers | 1 | 2025 | 421 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 186 | 0.050 |
Why?
| | Pancreatectomy | 1 | 2024 | 253 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 356 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 404 | 0.050 |
Why?
| | Demography | 1 | 2022 | 291 | 0.040 |
Why?
| | Ultrasonography | 1 | 2025 | 759 | 0.040 |
Why?
| | Health Policy | 1 | 2024 | 388 | 0.040 |
Why?
| | Gastrectomy | 1 | 2022 | 126 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2025 | 911 | 0.040 |
Why?
| | Child | 3 | 2025 | 21935 | 0.040 |
Why?
| | Child, Preschool | 2 | 2025 | 11074 | 0.040 |
Why?
| | Patient Safety | 1 | 2023 | 314 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2025 | 827 | 0.040 |
Why?
| | Inpatients | 1 | 2023 | 500 | 0.040 |
Why?
| | Hypoxia | 1 | 2025 | 1112 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 804 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 1069 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 787 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2828 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1381 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1692 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 6079 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2023 | 2654 | 0.020 |
Why?
| | Infant | 1 | 2025 | 9465 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6763 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2992 | 0.020 |
Why?
|
|
Beaty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|